Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Jun;35(6):1241–1242. doi: 10.1128/aac.35.6.1241

Long-term prophylaxis with norfloxacin versus nitrofurantoin in women with recurrent urinary tract infection.

R Raz 1, S Boger 1
PMCID: PMC284321  PMID: 1929272

Abstract

A total of 102 women with recurrent urinary tract infections were included in this open randomized study; 55 received 200 mg of norfloxacin daily and 47 received 50 mg of nitrofurantoin daily over 6 months. Fifty-three and 41 women from the norfloxacin- and nitrofurantoin-treated groups, respectively, completed the 6-month follow-up period. Forty-four (81%) of the norfloxacin-treated patients and 27 (65%) of the nitrofurantoin-treated patients remained free of symptoms (P = 0.05), and urine samples from 49 (92.4%) and 29 (70.7%) of the patients, respectively, were sterile (P less than 0.005). Side effects occurred with similar frequencies in both groups (15 and 17%) but were more severe in the women who received nitrofurantoin. Despite the better results obtained with norfloxacin, the difference in the costs of the two agents must be considered.

Full text

PDF
1241

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cox C. E., McCabe R. E., Grad C. Oral norfloxacin versus parenteral treatment of nosocomial urinary tract infection. Am J Med. 1987 Jun 26;82(6B):59–64. doi: 10.1016/0002-9343(87)90620-6. [DOI] [PubMed] [Google Scholar]
  2. Harding G. K., Buckwold F. J., Marrie T. J., Thompson L., Light R. B., Ronald A. R. Prophylaxis of recurrent urinary tract infection in female patients. Efficacy of low-dose, thrice-weekly therapy with trimethoprim-sulfamethoxazole. JAMA. 1979 Nov 2;242(18):1975–1977. [PubMed] [Google Scholar]
  3. Nicolle L. E., Harding G. K., Thompson M., Kennedy J., Urias B., Ronald A. R. Prospective, randomized, placebo-controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in women. Antimicrob Agents Chemother. 1989 Jul;33(7):1032–1035. doi: 10.1128/aac.33.7.1032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Stamey T. A., Condy M., Mihara G. Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections. Biologic effects on the vaginal and rectal flora. N Engl J Med. 1977 Apr 7;296(14):780–783. doi: 10.1056/NEJM197704072961403. [DOI] [PubMed] [Google Scholar]
  5. Stamey T. A., Timothy M., Millar M., Mihara G. Recurrent urinary infections in adult women. The role of introital enterobacteria. Calif Med. 1971 Jul;115(1):1–19. [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES